About PATHWAYS
Health pilot projects support Indigenous communities burdened with high rates of chronic diseases.
PATHWAYS is a collaboration between Boehringer Ingelheim (Canada) Ltd., Bimaadzwin and Indigenous health policy leaders from across Canada. Funding is available to advance national health and wellness projects that go “beyond the pill” in addressing type 2 diabetes and/or chronic obstructive pulmonary disease among Indigenous Peoples in Canada. Further investments in other chronic illnesses, such as interstitial lung disease, are planned following the successful launch of four initial pilot projects in 2021.
Pathways is paving the way for a brighter future one step at a time.
To bring communities closer to heal and to thrive.
Because we believe that health is not just the absence of disease.
It's about connection.
A sense of belonging.
A way of life.
And with every step we take...
We forge bonds between Indigenous communities...
The private sector and other partners using a distinction based approach.
We're addressing chronic diseases like Type 2 diabetes,
Chronic obstructive pulmonary disease, and rare diseases such as interstitial lung disease
That are impacting Indigenous people disproportionately.
Our success stories illuminate the path we walk.
We worked alongside Wagmatcook First Nation to integrate multidisciplinary care for diabetes patients through Healthy Choice
And to address food security in rural Nova Scotia.
We partnered with Siksika Health Services to use sensory insoles and digital monitoring of foot pressure to prevent complications
From diabetes and establish a robust care system.
We empowered the Metis Federation of Manitoba
To deliver better patient centered care for M�tis citizens.
In Baker Lake. We are working with Inuit youth to engage the community
To reduce the impact of Type 2 diabetes through education.
We've partnered with six nations to investigate the impact of food and water insecurity,
including food sovereignty, on the management of Type 2 diabetes for community members by promoting traditional foods.
We're working with Ebb and Flow First Nation Health Authority
To raise awareness and empower individuals through early intervention programs for diabetes management.
We worked with the Maskwacis to expand virtual healthcare,
Connecting more patients with practitioners and necessary resources.
In partnership with the Nuu-chah-nulth Tribal Council,
We supported healthcare staff in practicing culturally safe care,
Honoring the historical impacts and unique needs of Indigenous peoples
From coast to coast to coast.
Pathways is relationships.
Healing and empowerment for a brighter future.
For better health.
For hope and resilience.
About Bimaadzwin
An Indigenous-led consulting and policy group founded by former Ontario Regional Chief Isadore Day, Bimaadzwin’s focus is enabling First Nations communities to successfully reconstitute Nationhood by advancing health governance and economic development.
About Boehringer Ingelheim (Canada) Ltd.
Through our participation in medical and pharmaceutical research, both in Canada and worldwide, we have contributed to significant improvements in healthcare and developed innovative and cost effective medicines. We have earned a reputation as a leader in the treatment of respiratory diseases, in particular Chronic Obstructive Pulmonary Disease (COPD), and have broadened the scope of our work to include diseases such as hypertension, stroke, arthritis, benign prostatic hyperplasia (BPH), Parkinson's disease and HIV/AIDS.
We are constantly seeking new and better ways to treat people and animals. In the space of just two years, we have introduced several new products and have a number of new compounds in the pipeline. We have participated in joint ventures with other top multinational pharmaceutical companies - ventures that have improved quality of life for many thousands of Canadians and have perhaps saved the lives of thousands more.
While our German parent company stands among the world’s 20 largest human pharmaceutical research and development businesses, it has remained a family held company for over a century. As our ownership has remained unchanged, so have our guiding principles. Since our founding, we have practiced excellence, innovation and value in the discovery of medicines and services, and we have always acted in the firm knowledge that people and service are our priorities
We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.
The Canadian headquarters of Boehringer Ingelheim (Canada) Ltd. was established in 1972 in Montreal, Quebec and is now located in Burlington, Ontario.
For more information about Boehringer Ingelheim (Canada) Ltd. Visit the site.
